Bryon Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Peshawar · Pakistan
Peshawar-based pharmaceutical manufacturer producing a broad range of prescription and general medicines.
Bryon Pharmaceuticals products in Pakistan
Bryon Pharmaceuticals (Pvt.) Ltd has 120 medicine presentations registered in Pakistan under 59 brands, covering 53 generic medicines. Most of its products are in Cardiovascular, Anti-infectives and CNS & mental health. Its brands with the most registered strengths and packs are Corsafe VH (Amlodipine + Valsartan + Hydrochlorothiazide, Amlodipine + Valsartan), Corsafe AT (Amlodipine + Atorvastatin), Tyladol (Paracetamol) and Yasha-H (Valsartan + Hydrochlorothiazide). 120 products have an official DRAP price on MedInfoBase. See all 59 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Bryon Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 48 Hayatabad Industrial Estate, Hayatabad, Peshawar, Khyber Pakhtunkhwa, Pakistan
- Website
- bryon.com.pk ↗
- Phone
- +92 334 5817602
- info@bryon.com.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Bryon Pharmaceuticals (Pvt.) Ltd is priced against the market
106 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Flucon | Fluconazole | 50 mg | Capsule | 1x10's | 024639 | PKR 868.59 | PKR 86.86/capsule | 🔒 Pharma Pro |
| Flucon | Fluconazole | 50 mg/5 mL | Suspension | 35ml | 038193 | PKR 407.68 | PKR 11.65/mL | 🔒 Pharma Pro |
| Flucon | Fluconazole | 200 mg | Capsule | 4's | 085906 | PKR 885.87 | PKR 221.47/capsule | 🔒 Pharma Pro |
| Flucon 150 | Fluconazole | 150 mg | Capsule | 1x1's | 022401 | PKR 206.08 | PKR 206.08/capsule | 🔒 Pharma Pro |
| Gynosafe | Clotrimazole | 100 mg | Tablet | 2x3's | 027524 | PKR 194.13 | PKR 32.36/tablet | 🔒 Pharma Pro |
| Gynosafe | Clotrimazole | 500 mg | Vaginal insert | 1's | 027525 | PKR 174.72 | PKR 174.72/unit | No comparator |
| Gynosafe | Clotrimazole | 10%/5 g | Cream | 5gm | 049093 | PKR 203.13 | PKR 40.63/g | No comparator |
| Itrofit | Itraconazole | 100 mg | Capsule | 1x4's | 042965 | PKR 495.53 | PKR 123.88/capsule | 🔒 Pharma Pro |
| Nylosin | Nystatin | 100,000 units/mL | Oral suspension | 30ml | 060888 | PKR 35.32 | PKR 1.18/mL | No comparator |
| Terbizor | Terbinafine | 125 mg | Tablet | 1x10's | 064189 | PKR 464.43 | PKR 46.44/tablet | 🔒 Pharma Pro |
| Terbizor | Terbinafine | 10 mg/g (1%) | Cream | 10gm | 084238 | PKR 283.76 | PKR 28.38/g | 🔒 Pharma Pro |
| Terbizor | Terbinafine | 250 mg | Tablet | 1x10's | 084239 | PKR 795.28 | PKR 79.53/tablet | 🔒 Pharma Pro |
| TUBDO | Clotrimazole | 1% | Cream | 15gm | 110317 | PKR 90.52 | PKR 6.03/g | 🔒 Pharma Pro |
All 59 Bryon Pharmaceuticals brands in Pakistan
- Alben Albendazole · 200 mg tablet, 200 mg /5 mL suspension
- Amaze Bromazepam · 3 mg tablet
- Azibect Azithromycin · 250 mg capsule, 500 mg capsule
- Azibect 200 Azithromycin · 200 mg/5 mL suspension
- Bromifen Ibuprofen · 100 mg/5 mL suspension
- Brycef Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- Brycef DS Cefixime · 200 mg/5 mL suspension
- Brylax Lactulose · 3.35 g/5 mL syrup
- Bryzepam Diazepam · 10 mg tablet, 2 mg tablet, 5 mg tablet
- Caricard Atenolol · 100 mg tablet, 50 mg tablet
- Cebrin Ferrous sulfate + Folic acid · 200 mg + 0.1 mg capsule
- Cloxidil Clopidogrel · 75 mg tablet
- Corlet Isosorbide mononitrate · 20 mg tablet, 40 mg tablet
- Corsafe Amlodipine · 10 mg tablet, 5 mg tablet
- Corsafe - V 10 Amlodipine + Valsartan · 10 mg + 160 mg tablet
- Corsafe - V 5 Amlodipine + Valsartan · 5 mg + 160 mg tablet
- Corsafe AT Amlodipine + Atorvastatin · 10 mg + 10 mg tablet, 10 mg + 20 mg tablet
- Corsafe AT 10/10 Amlodipine + Atorvastatin · 10 mg + 10 mg tablet
- Corsafe VH Amlodipine + Valsartan + Hydrochlorothiazide, Amlodipine + Valsartan · 10 mg + 160 mg + 12.5 mg tablet, 10 mg + 160 mg + 25 mg tablet, 10 mg + 320 mg + 25 mg tablet
- Corsafe-V 5 Amlodipine + Valsartan · 5 mg + 80 mg tablet
- Doxyclate Doxycycline · 100 mg capsule
- Enpril Enalapril · 10 mg tablet, 5 mg tablet
- Epilex Carbamazepine · 100 mg/5 mL suspension, 200 mg tablet
- Ferrocebrin-F Iron protein succinylate + Folic acid · 20 mg + 2.5 mg tablet
- Flectin Fluoxetine · 20 mg capsule, 20 mg/5 mL syrup
- Flovix 200 Ofloxacin · 200 mg tablet
- Flucon Fluconazole · 200 mg capsule, 50 mg capsule, 50 mg/5 mL suspension
- Flucon 150 Fluconazole · 150 mg capsule
- Fluxaquin Moxifloxacin · 400 mg tablet
- Glipomet Sitagliptin + Metformin · 50 mg + 500 mg tablet
- Gynosafe Clotrimazole · 10%/5 g cream, 100 mg tablet, 500 mg vaginal insert
- Itrofit Itraconazole · 100 mg capsule
- Leoflox Levofloxacin · 250 mg tablet, 500 mg tablet
- Lokestrol Simvastatin · 10 mg tablet, 20 mg tablet
- Lokit Loperamide HCl · 2 mg capsule
- Loragix Loratadine · 10 mg tablet, 5 mg/5 mL solution
- Losaten Losartan, Losartan + Hydrochlorothiazide · 50 mg tablet, 50 mg + 12.50 mg tablet
- Nobilium Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Nylosin Nystatin · 100,000 units/mL suspension
- Olzar Olanzapine · 10 mg tablet, 5 mg tablet, 7.5 mg tablet
- Orfatec Paracetamol + Orphenadrine · 450 mg + 35 mg tablet
- Ostrin Sulfamethoxazole + Trimethoprim, Sulfamethoxazole · 200 mg + 40 mg/5 mL suspension, 400 mg tablet
- Ostrin Forte Sulfamethoxazole + Trimethoprim · 400 mg + 80 mg/10 mL suspension, 800 mg + 160 mg tablet
- Pamlore Lorazepam · 1 mg tablet, 2 mg tablet
- Polycebrin-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
- Sopral Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Sopral Plus Bisoprolol + Hydrochlorothiazide · 10 mg + 6.25 mg tablet, 5 mg + 6.25 mg tablet
- Terbizor Terbinafine · 10 mg/g (1%) cream, 125 mg tablet, 250 mg tablet
- TUBDO Clotrimazole · 1% cream
- Tyladol Paracetamol · 120 mg/5 mL suspension, 250 mg/5 mL suspension, 500 mg tablet
- Tyladol CF Paracetamol + Pseudoephedrine + Chlorpheniramine · 500 mg + 60 mg + 4 mg tablet
- Tyladol Extra Paracetamol + Caffeine · 500 mg + 65 mg tablet
- Tylagesic (Tramadol Hydrochloride + Acetaminophen Tramadol + Paracetamol · 37.5 mg + 325 mg tablet
- Volpar Divalproex sodium · 250 mg tablet, 500 mg tablet
- Yasha-H Valsartan + Hydrochlorothiazide · 160 mg + 12.5 mg tablet, 160 mg + 25 mg tablet, 80 mg + 12.5 mg tablet
- Zeclorin Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Zepep Omeprazole · 20 mg capsule, 40 mg capsule
- Zepep Plus Omeprazole + Sodium bicarbonate · 20 mg + 1100 mg capsule, 40 mg + 1100 mg capsule
- Zoloxin Ciprofloxacin · 250 mg tablet, 500 mg tablet
Bryon Pharmaceuticals: common questions
How many products does Bryon Pharmaceuticals have in Pakistan?
Bryon Pharmaceuticals (Pvt.) Ltd has 120 registered medicine presentations in Pakistan, sold under 59 brands and covering 53 generic medicines.
What are the main brands of Bryon Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Corsafe VH (Amlodipine + Valsartan + Hydrochlorothiazide, Amlodipine + Valsartan), Corsafe AT (Amlodipine + Atorvastatin), Tyladol (Paracetamol), Yasha-H (Valsartan + Hydrochlorothiazide) and Bryzepam (Diazepam). This is not a sales ranking.
Which therapy areas does Bryon Pharmaceuticals cover?
The most products are in Cardiovascular (41), Anti-infectives (35), CNS & mental health (18), Pain & musculoskeletal (9) and Gastrointestinal & hepatology (8).
Where can I see Bryon Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.